AMGEN INC et al v. MYLAN INC. et al
AMGEN INC and AMGEN MANUFACTURING LIMITED |
MYLAN GMBH, MYLAN PHARMACEUTICALS INC, MYLAN INC. and MYLAN N.V. |
HOSPIRA, INC. |
2:2017cv01235 |
September 22, 2017 |
US District Court for the Western District of Pennsylvania |
Pittsburgh Office |
XX US, Outside State |
Mark R Hornak |
Patent |
35 U.S.C. § 271 |
Both |
Docket Report
This docket was last retrieved on February 19, 2020. A more recent docket listing may be available from PACER.
Document Text |
---|
|
Filing 286 STIPULATION re Costs by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Wolski, Thomas) |
Filing 285 BILL OF COSTS by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC in the amount of $114,738.62 against Amgen Inc. and Amgen Manufacturing Limited. (Attachments: #1 Affidavit of Natasha White) (Soller, Eric) |
Filing 284 NOTIFICATION of Decision sent to Commissioner of Patents and Trademarks re #283 Order. (Attachments: #1 Judgment) (cjo) |
|
Filing 282 STATUS REPORT by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C) (Baldauf, Kent) |
Filing 281 NOTIFICATION of Decision sent to Commissioner of Patents and Trademarks re #280 Order Staying Case, Administratively Closing the Case, Set Deadlines. (ept) Modified text on 8/27/2019. (ept) |
|
Filing 279 STATUS REPORT by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit A) (Baldauf, Kent) |
|
Filing 277 RESPONSE to #276 Notice,, filed by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit A) (Baldauf, Kent) |
Filing 276 NOTICE of supplemental authority in support of its Rule 12(c) Renewed Motion for Judgment on the Pleadings Regarding U.S. Patent No. 8,273,707 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC re #214 Sealed Document, #193 Sealed Document, #191 Motion for Judgment on the Pleadings (Attachments: #1 Exhibit A) (Soller, Eric) |
|
Filing 274 Unopposed MOTION to Withdraw as Attorney for Rachel A. Smoot by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
|
Filing 272 JOINT STATUS REPORT by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit A) (Baldauf, Kent) |
|
Filing 270 MOTION for attorney Paula S. Fritsch to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-5194232) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order, #2 Affidavit) (Fritsch, Paula) |
Filing 269 REPLY BRIEF re #197 Motion for Summary Judgment (Supplemental) filed by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric) |
Filing 268 SUPPLEMENTAL RESPONSE IN OPPOSITION to Mylan's #197 Motion for Summary Judgment of Non-Infringement re U.S. Patent No. 9,643,997 filed by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit A, #2 Exhibit B) (Baldauf, Kent) Modified text on 6/24/2019 to add document linkage. (ept) |
|
Filing 266 Errata re #265 Notice Regarding Third Party Subpoenas by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. Reason for Correction: Correct spelling error. (Soller, Eric) |
Filing 265 NOTICE Regarding Third Party Subpoenas by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC re #264 Order,, Terminate Motions,, Set Deadlines, (Soller, Eric) Document removed from public view and redocketed at #266 . Modified text on 6/14/2019. (ept) |
|
Filing 263 Minute Entry for proceedings held before Chief Judge Mark R. Hornak: Telephonic Status Conference held on 6/10/19. (Court Reporter: Karen Earley) (jad) |
|
|
Filing 260 Unopposed MOTION for Extension of Time to File Response/Reply as to #258 First MOTION to Quash SUBPOENA TO PRODUCE DOCUMENTS by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
Filing 259 BRIEF in Support re #258 Motion to Quash SUBPOENA TO PRODUCE DOCUMENTS filed by HOSPIRA, INC.. (Attachments: #1 Affidavit) (Thomas, Emily) |
Filing 258 First MOTION to Quash SUBPOENA TO PRODUCE DOCUMENTS by HOSPIRA, INC.. (Attachments: #1 Proposed Order) (Thomas, Emily) |
Filing 257 Proposed Order re #254 Motion for Miscellaneous Relief parties Joint Motion for a Status Conference to Resolve the Parties Case Management Disputes (ECF No. 254) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric) |
|
CLERK'S OFFICE QUALITY CONTROL MESSAGE re #254 Motion for a Status Conference to Resolve the Parties Case Management Disputes. ERROR: Proposed Order was not attached. CORRECTION: Attorney is advised to file a proposed order by using the Proposed Order event and linking it to the document in question. (ept) |
Filing 255 Unopposed MOTION to Withdraw as Attorney (Stephen A. Maniscalco) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
Filing 254 Joint MOTION for a Status Conference to Resolve the Parties Case Management Disputes by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 1, #2 Exhibit 2) (Soller, Eric) |
|
|
Filing 251 MOTION for attorney Aaron J. Marks to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-5148129) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Marks, Aaron) |
Filing 250 Unopposed MOTION for Leave to File Documents Under Seal Joint Motion for a Status Conference to Resolve the Parties Case Management Disputes by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) Modified text on 5/22/2019. (ept) |
|
Filing 248 MOTION for attorney John D. Polivick to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-5139693) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit A, #2 Proposed Order) (Polivick, John) |
|
Filing 246 Joint MOTION for Extension of Time to Complete Discovery Joint Motion for Extension of Substantial Completion of Damages-Related Document Production by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
|
Filing 244 SEALED DOCUMENT (response to statement of disputed facts) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #238 Order on Motion for Leave to File Documents Under Seal. (ept) |
Filing 243 SEALED DOCUMENT (Declaration of Eric R Hunt in support of motion for summary judgment of non-infringement) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #238 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I) (ept) |
Filing 242 SEALED DOCUMENT (reply brief in support of summary judgment of non-infringement regardng U.S. Patent No. 9,643,997) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #238 Order on Motion for Leave to File Documents Under Seal. (ept) |
Filing 241 REDACTION to #197 MOTION for Summary Judgment of non-infringement regarding U.S. Patent No. 9,643,997 Redacted Declaration of Eric R. Hunt In Support of Mylans Motion for Summary Judgment of Non-Infringement by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I) (Soller, Eric) |
Filing 240 REDACTION to #223 Redacted Document Redacted REDACTED Mylan Response to Statement of Disputed Facts by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric) |
Filing 239 REDACTION to #197 MOTION for Summary Judgment of non-infringement regarding U.S. Patent No. 9,643,997 Redacted Reply Brief in Support of Mylans Motion for Summary Judgment of Non-Infringement Regarding U.S. Patent No. 9,643,997 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric) |
|
Filing 237 Unopposed MOTION for Leave to File Documents Under Seal Mylans Reply Brief in Support of its Motion for Summary Judgment of Non-Infringement Regarding U.S. Patent No. 9,643,997 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
Filing 236 SEALED DOCUMENT (Answer to Counterclaims Asserted in its Answer to the First Amended and Supplemental Complaint) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #234 Order on Motion for Leave to File Documents Under Seal. (ept) |
Filing 235 REDACTION Answer to Defendant Mylan GmbH's Counterclaims Asserted in Answer to First Amended & Supplemental Complaint by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent) |
|
Filing 233 Unopposed MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
|
Filing 231 MOTION for attorney Naz E. Wehrli to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-5055738) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Wehrli, Naz) |
|
Filing 229 Unopposed MOTION for Extension of Time to File Response/Reply Reply Brief in Support of Defendants Motion for Summary Judgment of Non-Infringement Regarding U.S. Patent No. 9,643,997 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
Filing 228 SEALED DOCUMENT (Jennifer Gordon Declaration in support of Response in Opposition) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #219 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F) (ept) |
Filing 227 SEALED DOCUMENT (Harvey Blanch Declaration in support of Response in Opposition) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #219 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit 2, #2 Exhibit 3, #3 Exhibit 19, #4 Exhibit 20, #5 Exhibit 21, #6 Exhibit 22) (ept) |
Filing 226 SEALED DOCUMENT (Response in Opposition to Motion for Summary Judgment) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #219 Order on Motion for Leave to File Documents Under Seal. (ept) |
Filing 225 SEALED DOCUMENT (Statement of Disputed Facts) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #219 Order on Motion for Leave to File Documents Under Seal. (ept) |
Filing 224 REDACTION Declaration of Harvey Blanch in Support of Response in Opposition to Mylan's Motion for Summary Judgment by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22) (Baldauf, Kent) |
Filing 223 REDACTION Statement of Disputed Facts by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent) |
Filing 222 REDACTION Declaration of Jennifer Gordon in Support of Response in Opposition to Mylan's Motion for Summary Judgment by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F) (Baldauf, Kent) |
Filing 221 REDACTION Response in Opposition to Mylan's Motion for Summary Judgment by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent) |
Filing 220 ANSWER to #210 Amended Complaint , COUNTERCLAIM against AMGEN INC., AMGEN MANUFACTURING LIMITED by MYLAN PHARMACEUTICALS INC, MYLAN GMBH, MYLAN N.V., MYLAN INC. (Soller, Eric) Modified text on 3/1/2019. (ept) |
|
Filing 218 Unopposed MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
|
Filing 216 Unopposed MOTION for Extension of Time to File Answer re #210 Amended Complaint, filed by AMGEN MANUFACTURING LIMITED, AMGEN INC by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
Filing 215 Errata re #213 Redacted Document, Reply Brief in Support of Mylan's Renewed Motion for Judgment on the Pleadings Pursuant to Rule 12(C) Regarding U.S. Patent No. 8,273,707 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. Reason for Correction: correct missing signature and correct to conform to sealed version. (Soller, Eric) |
Filing 214 SEALED DOCUMENT (Reply Brief in Support of Mylan's Renewed Motion for Judgment on the Pleadings Pursuant to Rule 12(C) Regarding U.S. Patent No. 8,273,707) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #212 Order on Motion for Leave to File Documents Under Seal. (ept) |
CLERK'S OFFICE QUALITY CONTROL MESSAGE re #213 Redacted Document. ERROR: Typed name omitted by s/. CORRECTION: Attorney advised of signature requirements. Attorney to resubmit with signature, using Errata event. (ept) |
Filing 213 REDACTION to #191 Renewed MOTION for Judgment on the Pleadings Pleadings Pursuant to Rule 12(c) Regarding U.S. Patent No. 8,273,707 Reply Brief in support Motion for Judgment on the Pleadings regarding the 707 patent by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 7) (Soller, Eric) Document removed from public view and redocketed at #215 . Modified text on 2/15/2019. (ept) |
|
Filing 211 Unopposed MOTION for Leave to File Documents Under Seal Seal Mylans Reply Brief in Support of its Renewed Motion for Judgment on the Pleadings Pursuant to Rule 12(c) Regarding U.S. Patent No. 8,273,707 B2 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
Update Answer Deadline: Answer due from MYLAN GMBH on 2/21/2019; MYLAN INC. on 2/21/2019; MYLAN N.V. on 2/21/2019; MYLAN PHARMACEUTICALS INC on 2/21/2019 (ept) |
Filing 210 First AMENDED COMPLAINT against MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC, filed by AMGEN MANUFACTURING LIMITED, AMGEN INC. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17) (Baldauf, Kent) |
|
Filing 208 SEALED DOCUMENT (Response in Opposition to Mylan's Renewed Motion for Judgment on the Pleadings Pusuant to Rule 12(C) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to 203 Order on Motion for Leave to File Documents Under Seal. (ept) |
Filing 207 REDACTION Response in Opposition to Mylan's Renewed Motion for Judgment on the Pleadings by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent) |
Filing 206 BRIEF in Support re #205 Motion for Leave to File an Amended and Supplemental Complaint filed by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit 1) (Baldauf, Kent) |
Filing 205 Unopposed MOTION for Leave to File an Amended and Supplemental Complaint by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
|
|
Filing 202 SEALED DOCUMENT (Concise Statement of Material Facts in Support of Motion for Summary Judgment) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #195 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11) (ept) |
Filing 201 SEALED DOCUMENT (Brief in Support of Motion for Summary Judgment) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #195 Order on Motion for Leave to File Documents Under Seal. (ept) |
Filing 200 MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
Filing 199 REDACTION Brief in Support of Motion for Summary Judgment of Non-Infringement Regarding U.S. Patent No. 9,643,997 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric) |
Filing 198 REDACTION Concise Statement of Material Facts in Support of Motion for Summary Judgment of Non-infringement Regarding US Patent No. 9,643,997 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11) (Soller, Eric) |
Filing 197 MOTION for Summary Judgment of non-infringement regarding U.S. Patent No. 9,643,997 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
Filing 196 Proposed Case Management Order (Revised) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent) |
|
Filing 194 Unopposed MOTION for Leave to File Documents Under Seal Mylans Motion for Summary Judgment of Non-Infringement Regarding U.S. Patent No. 9,643,997 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
Filing 193 SEALED DOCUMENT (Brief in Support of Renewed Motion for Judgment on the Pleadings) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #190 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6) (ept) |
Filing 192 REDACTION to #191 Renewed MOTION for Judgment on the Pleadings Pleadings Pursuant to Rule 12(c) Regarding U.S. Patent No. 8,273,707 Redacted Brief in Support of Renewed MOTION for Judgment on the Pleadings by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6) (Soller, Eric) |
Filing 191 Renewed MOTION for Judgment on the Pleadings Pleadings Pursuant to Rule 12(c) Regarding U.S. Patent No. 8,273,707 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
|
Filing 189 Unopposed MOTION for Leave to File Documents Under Seal by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
|
Filing 187 SEALED DOCUMENT (Response to Plaintiff's Statement Pursuant to the Court's December 17, 2018 Order) by MYLAN GMBH, MYLAN INC., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #185 Order on Motion for Leave to File, Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4) (ept) |
Filing 186 REDACTION to #182 Redacted Document, #183 Sealed Document, Response To Plaintiffs' Statement Pursuant to the Court's December 17, 2018 Order by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4) (Soller, Eric) |
|
Filing 184 MOTION for Leave to File Response to Statement regarding Amended Infringement Contentions , MOTION for Leave to File Documents Under Seal by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
Filing 183 SEALED DOCUMENT (Statement Pursuant to the Court's December 17, 2018 Order) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #180 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit) (ept) |
Filing 182 REDACTION Statement Pursuant to the Court's December 17, 2018 Order by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit 1) (Baldauf, Kent) |
|
|
Filing 179 Unopposed MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
|
Filing 177 STATUS REPORT by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent) |
|
Filing 175 Joint MOTION to Set the Deadlines for Amgen to Serve Amended Infringement Contentions and for Mylan to Serve Amended Invalidity and Non-Infringement Contentions by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
|
Filing 173 Joint MOTION to Stay the December 7, 2018 Deadline to Move to Amend the Pleadings or Add New Parties by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
|
Filing 171 OPINION. Signed by Judge Mark R. Hornak on 11/20/18. (jad) |
|
Remark: Attorney to disregard the 11/6/2018 quality control message, since attorney John Schwab explained the Notice of Deposition was signed by the plaintiffs' attorney and then filed by the defendants. (ept) |
CLERK'S OFFICE QUALITY CONTROL MESSAGE re #167 Notice of Video Deposition. ERROR: Signature on document and filer do not match. CORRECTION: Attorney advised of signature requirements. Attorney to resubmit the document using the Errata event. (ept) |
Filing 169 SEALED DOCUMENT (Responses and Objections to Amgen's Notice of Video Deposition) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #166 Order on Motion for Leave to File Documents Under Seal. (ept) |
Filing 168 SEALED DOCUMENT (Notice of Video Deposition) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #166 Order on Motion for Leave to File Documents Under Seal. (ept) |
Filing 167 NOTICE Plaintiffs Notice of Video Deposition by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC re 164 Order, (Attachments: #1 Defendants' Objections) (Schwab, John) |
|
Filing 165 Unopposed MOTION for Leave to File Documents Under Seal by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Schwab, John) |
|
Filing 163 NOTICE - Joint Request for a Status Conference by AMGEN INC, AMGEN MANUFACTURING LIMITED (Baldauf, Kent) |
|
Filing 161 NOTICE - Joint Statement of Position by AMGEN INC, AMGEN MANUFACTURING LIMITED re #159 Order, Set Deadlines, (Baldauf, Kent) |
Filing 160 NOTICE OF FILING OF OFFICIAL TRANSCRIPT of Proceedings re Claims Construction held on September 21, 2018 before Judge Mark R. Hornak. Court Reporter Karen M. Earley, Telephone number 412-201-2660. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely, electronically available to the public without redaction after 90 calendar days. For redaction purposes, or otherwise, during this 90 day period a copy of the transcript may be purchased from the court reporter or viewed at the clerk's office public terminal. Any Notice of Intent to Request Redaction and Redaction Request must be separately mailed to the court reporter of said proceedings. Notice of Intent for Redaction of Personal Data Identifiers due by 10/17/2018. Redaction Request due 10/31/2018. Redacted Transcript Deadline set for 11/13/2018. Release of Transcript Restriction set for 1/8/2019. (kme) |
|
Filing 158 STIPULATION Regarding Previously Disputed Claim Term by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent) |
Filing 157 Minute Entry for proceedings held before Judge Mark R. Hornak: Claim Construction Hearing held on 9/21/2018. (Court Reporter: Karen Earley) (jad) |
|
|
Filing 154 Unopposed MOTION for Leave to File / Amend its Disclosure of Asserted Claims and Infringement Contentions by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
Filing 153 Unopposed MOTION to Withdraw #149 MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
Filing 152 Minute Entry for proceedings held before Judge Mark R. Hornak: Telephonic Status Conference held on 9/17/18. (Court Reporter: Shirley Hall) (jad) |
|
|
Filing 149 MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
Filing 148 STATUS REPORT (Joint) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent) |
|
Filing 146 STIPULATION Regarding Biocon Ltd. by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent) |
|
Filing 144 MOTION for attorney Eric M. Agovino to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4846057) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Agovino, Eric) |
|
Filing 142 MOTION for attorney David J. Ball Jr. to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4841732) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Ball, David) |
Filing 141 SEALED DOCUMENT (Statement of Position as to Bifurcation or Delay of Damages and Remedial Discovery) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #134 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14) (ept) |
Filing 140 SEALED DOCUMENT (Exhibit #7 is the main document) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #137 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit 8, #2 Exhibit 9, #3 Exhibit 10) (ept) |
Filing 139 REDACTION Position Statement by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14) (Schwab, John) |
Filing 138 REDACTION Statement of Position as to Bifurcation/Delay in Damages and Remedial Discovery by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10) (Baldauf, Kent) |
|
Filing 136 MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
Filing 135 NOTICE OF FILING OF OFFICIAL TRANSCRIPT of Proceedings re Telephone Status Conference held on August 3, 2018 before Judge Mark R. Hornak. Court Reporter Juliann A. Kienzle, Telephone number 412.261.6122. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely, electronically available to the public without redaction after 90 calendar days. For redaction purposes, or otherwise, during this 90 day period a copy of the transcript may be purchased from the court reporter or viewed at the clerk's office public terminal. Any Notice of Intent to Request Redaction and Redaction Request must be separately mailed to the court reporter of said proceedings. Notice of Intent for Redaction of Personal Data Identifiers due by 8/28/2018. Redaction Request due 9/11/2018. Redacted Transcript Deadline set for 9/21/2018. Release of Transcript Restriction set for 11/19/2018. (jak) |
|
Filing 133 MOTION for Leave to File Documents Under Seal Statement of Position as to Bifurcation Or Delay of Damages and Remedial Discovery by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
Filing 132 Sur-Reply Brief on Claim Construction re #130 Sur-Reply Brief, filed by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent) |
|
Filing 130 Sur-Reply Brief on Claim Construction re #114 Reply Brief, filed by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 1) (Soller, Eric) |
|
Filing 128 Minute Entry for proceedings held before Judge Mark R. Hornak: Telephonic Status Conference held on 8/3/18. (Court Reporter: Julie Kienzle) (bdb) |
|
Filing 126 REPLY re #124 Motion for Leave to File Surreply Brief filed by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric) Modified on 7/30/2018 to correct title of event selected. (ept) |
Filing 125 RESPONSE IN OPPOSITION to #124 Motion for Leave to File, filed by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent) |
Filing 124 MOTION for Leave to File Surreply Brief on Claim Construction by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
Filing 123 REPORT of Mediation: Case has not been resolved. The parties are reminded of their obligation to complete the ADR questionnaire and submit within 5 days of the conclusion of the ADR process. The questionnaire can be accessed at www.pawd.uscourts.gov. Click on the ADR icon. Mediation session was held on 5/23/2018. (Soller, Eric) |
|
Filing 121 AT&T SCHEDULING NOTICE FOR ALL TELEPHONIC CONFERENCES. Every Telephonic Conference conducted will be via an AT&T call-in number which requires participants to dial-in and provide an access code. When a Telephonic Conference is scheduled you will be instructed to refer back to this Notice and use either Dial-In No. 1 or Dial-In No. 2, both of which are contained in this Notice. This document has a security setting of "Case Participants Only", so only those individuals will have access to view the document. (jad) |
|
Filing 119 Joint MOTION for a Status Conference by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
Filing 118 MOTION for Removal of Document No. 116 from the Court Docket and/or from Public View re #116 Declaration filed by AMGEN MANUFACTURING LIMITED, AMGEN INC by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Wolski, Thomas) |
Filing 117 DECLARATION re #114 Reply Brief by AMGEN INC, AMGEN MANUFACTURING LIMITED Affiant: Richard C. Willson. (Attachments: #1 Exhibit A) (Wolski, Thomas) |
Filing 116 DECLARATION re #114 Reply Brief by AMGEN INC, AMGEN MANUFACTURING LIMITED Affiant: Richard C. Willson. (Attachments: #1 Exhibit A) (Wolski, Thomas) Modified on 7/24/2018 to remove document from public view. (ksa) |
Filing 115 NOTICE - Supplemental Identification of Extrinsic Evidence by AMGEN INC, AMGEN MANUFACTURING LIMITED re #106 Redacted Document (Wolski, Thomas) |
Filing 114 REPLY BRIEF re #106 Redacted Document - Opening Claim Construction Brief filed by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit 1) (Wolski, Thomas) |
|
Filing 112 MOTION to Withdraw as Attorney Attorney Guylaine Hache by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
Filing 111 NOTICE Identification of Extrinsic Evidence by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC (Attachments: #1 Exhibit A-Declaration of Jungbauer, #2 Exhibit A to Declaration of Jungbauer, #3 Exhibit B-Declaration of Georgiou, #4 Exhibit A to Declaration of Georgiou, #5 Exhibit B to Declaration of Georgiou, #6 Exhibit C to Declaration of Georgiou, #7 Exhibit 1, #8 Exhibit 2, #9 Exhibit 3, #10 Exhibit 4, #11 Exhibit 5, #12 Exhibit 6, #13 Exhibit 7, #14 Exhibit 8, #15 Exhibit 9, #16 Exhibit 10, #17 Exhibit 11, #18 Exhibit 12, #19 Exhibit 13) (Soller, Eric) |
Filing 110 RESPONSE to Opening Claim Construction Brief to #106 Redacted Document, filed by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric) |
Filing 109 SEALED DOCUMENT by AMGEN INC. This document Sealed pursuant to #105 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit 1, #2 Exhibit 3) (plh) |
Filing 108 DECLARATION re #106 Redacted Document Opening Claim Construction Brief by AMGEN INC, AMGEN MANUFACTURING LIMITED Affiant: Richard C. Willson. (Attachments: #1 Appendix A) (Baldauf, Kent) |
Filing 107 NOTICE - Identification of Extrinsic Evidence [LPR 4.3] by AMGEN INC, AMGEN MANUFACTURING LIMITED re #106 Redacted Document (Baldauf, Kent) |
Filing 106 REDACTION Opening Claim Construction Brief by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit 1 (Redacted in its Entirety), #2 Exhibit 2, #3 Exhibit 3 (Redacted in its Entirety)) (Baldauf, Kent) |
|
Filing 104 MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
Filing 103 Errata re #100 CLAIM Construction Chart -Parties' Joint Disputed Claim Terms Chart & Prehearing Statement by AMGEN INC, AMGEN MANUFACTURING LIMITED. Reason for Correction: Missing Attachments. (Attachments: #1 Joint Disputed Claim Terms Chart, #2 CV - Rito-Palomares, #3 CV - Willson, #4 CV - Jungbauer, #5 CV - Radtke, #6 CV - Georgiou) (Baldauf, Kent) |
Filing 102 Appendix to #100 CLAIM Construction Chart by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12) (Soller, Eric) Modified on 5/18/2018. (plh) |
Filing 101 Appendix of Intrinsic Evidence by AMGEN INC, AMGEN MANUFACTURING LIMITED re #100 CLAIM Construction Chart (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6) (Baldauf, Kent) Modified on 5/17/2018. (plh) |
Filing 100 CLAIM Construction Chart - Parties' Joint Disputed Claim Terms Chart & Prehearing Statement by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Joint Disputed Claim Terms Chart) (Baldauf, Kent) Modified on 6/1/2018. (plh) |
|
Filing 98 Joint MOTION for Extension of Time to File Joint Disputed Claim Terms Chart & Prehearing Statement by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
Filing 97 SEALED DOCUMENT by MYLAN GMBH, MYLAN INC., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #94 Order on Motion for Leave to File Documents Under Seal (plh) |
Filing 96 Errata re #95 Redacted Document Reply Brief In Support Of Mylans Motion For Judgment On The Pleadings Pursuant To Rule 12(C) Regarding U.S. Patent No. 8,273,707 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. Reason for Correction: filing lacking signature. (Soller, Eric) |
Filing 95 REDACTION Reply Brief In Support Of Mylans Motion For Judgment On The Pleadings Pursuant To Rule 12(C) Regarding U.S. Patent No. 8,273,707 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric) Modified on 5/14/2018. (plh) Document removed from public view SEE ERRATA at Doc. #96 . |
|
Filing 93 Unopposed MOTION for Leave to File Documents Under Seal Reply Brief in Support of its Motion for Judgment on the Pleadings by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
|
Filing 91 Joint MOTION to Amend/Correct #65 Case Management Order by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
Filing 90 Errata re #86 Redacted Document, Response in Opposition to Defendants' Motion for Judgment on the Pleadings by AMGEN INC, AMGEN MANUFACTURING LIMITED. Reason for Correction: incomplete redaction of previously filed document. (Attachments: #1 Exhibit 1 (Redacted in its entirety), #2 Exhibit 2 (Redacted in its entirety), #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11) (Baldauf, Kent) |
|
Filing 88 Unopposed MOTION to Extend Time to May 11, 2018, MOTION for Extension of Time to File Response/Reply as to #86 Redacted Document, #87 Sealed Document by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
Filing 87 SEALED DOCUMENT by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #84 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit 1, #2 Exhibit 2) (plh) |
Filing 86 REDACTION Response in Opposition to Defendants' Motion for Judgment on the Pleadings by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit 1 (Redacted in its Entirety), #2 Exhibit 2 (Redacted in its Entirety), #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11) (Baldauf, Kent) Modified on 5/2/2018. (plh) Document removed from public view SEE ERRATA at Doc. #90 for corrections. |
|
|
Filing 83 MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
Filing 82 Unopposed MOTION for Extension of Time to File Response to Defendants' Motion for Judgment on the Pleadings by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
Filing 81 SEALED DOCUMENT by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #78 Order on Motion for Leave to File Documents Under Seal, (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10) (plh) |
Filing 80 REDACTION to Brief by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10) (Soller, Eric) |
Filing 79 MOTION for Judgment on the Pleadings Pursuant to Rule 12(c) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
|
Filing 77 Unopposed MOTION for Leave to File Documents Under Seal by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
Filing 76 STIPULATION selecting ADR process by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent) |
|
Filing 74 Joint MOTION for Extension of Time to File Updated Stipulation Selecting ADR Process by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) |
|
Filing 72 Joint MOTION for Extension of Time to File Updated Stipulation Selecting ADR Process by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
|
|
Filing 69 STIPULATED PROTECTIVE ORDER by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent) |
Filing 68 Joint MOTION for Extension of Time to File Updated Stipulation Selecting ADR Process by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
|
Filing 66 JOINT STATUS REPORT by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric) |
|
Filing 64 Proposed Case Management Order by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Wolski, Thomas) |
Filing 63 NOTICE OF FILING OF OFFICIAL TRANSCRIPT of Proceedings held on January 10, 2018 before Judge Mark R. Hornak. Court Reporter Richard Ford, Telephone number (412) 261-0802. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely, electronically available to the public without redaction after 90 calendar days. For redaction purposes, or otherwise, during this 90 day period a copy of the transcript may be purchased from the court reporter or viewed at the clerk's office public terminal. Any Notice of Intent to Request Redaction and Redaction Request must be separately mailed to the court reporter of said proceedings. Notice of Intent for Redaction of Personal Data Identifiers due by 1/24/2018. Redaction Request due 2/7/2018. Redacted Transcript Deadline set for 2/20/2018. Release of Transcript Restriction set for 4/17/2018. (rtf) |
|
Filing 61 Minute Entry for proceedings held before Judge Mark R. Hornak: Telephonic Initial Case Management Conference held on 1/10/18. (Court Reporter: Richard Ford) (jad) |
|
|
|
|
Filing 56 MOTION for attorney Kimberlin L. Morley to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4582025) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Morley, Kimberlin) |
Filing 55 MOTION for attorney Lois Kwasigroch to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4582008) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Kwasigroch, Lois) |
Filing 54 MOTION for attorney Wendy A. Whiteford to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4581994) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Whiteford, Wendy ) |
Filing 53 SEALED DOCUMENT (Answer to Counterclaims) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #34 Order on Motion for Leave to File Documents Under Seal. (ept) |
Filing 52 REDACTION Answer to Defendant Mylan GmbH's Counterclaims by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Wolski, Thomas) |
Filing 51 Proposed Initial Scheduling Order by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Wolski, Thomas) |
Filing 50 STIPULATION selecting ADR process by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Wolski, Thomas) |
Filing 49 REPORT of Rule 26(f) Planning Meeting. (Wolski, Thomas) |
|
|
|
|
|
|
|
Filing 41 MOTION for attorney Golda Lai to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4569753) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Lai, Golda) |
Filing 40 MOTION for attorney Jacob T. Whitt to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4569752) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Whitt, Jacob) |
Filing 39 MOTION for attorney Stephen A. Maniscalco to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4569750) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Maniscalco, Stephen) |
Filing 38 MOTION for attorney Peter Sandel to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4569749) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Sandel, Peter) |
Filing 37 MOTION for attorney Jennifer Gordon to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4569748) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Gordon, Jennifer) |
Filing 36 MOTION for attorney Jennifer H. Wu to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4569747) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Wu, Jennifer) |
Filing 35 MOTION for attorney Nicholas Groombridge to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4569746) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Groombridge, Nicholas) |
|
Filing 33 Minute Entry for proceedings held before Judge Mark R. Hornak: Telephonic Status Conference held on 12/19/17. (Court Reporter: Richard Ford) (jad) |
|
NOTICE to Counsel. Please disregard the "Order Rescheduling Conference" for the Conference set for 12/19/17 at 3:00 PM. The Conference is still scheduled for December 19, 2017 at 3:00 PM. (jad) |
|
Filing 30 MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent) |
|
Filing 28 Disclosure Statement identifying none as corporate parent and MYLAN GmbH, Mylan N.V. and Mylan Pharmaceuticals Inc as affiliates, by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric) Modified on 11/24/2017 to add names of affiliates. (ksa) |
Filing 27 ANSWER to #1 Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by MYLAN PHARMACEUTICALS INC, MYLAN N.V., MYLAN GMBH, MYLAN INC.. (Soller, Eric) |
|
|
|
|
|
|
|
Filing 19 MOTION for attorney Guylaine Hache to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4494012) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Affidavit, #2 Proposed Order) (Hache, Guylaine) |
Filing 18 MOTION for attorney Rachel A. Smoot to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4494003) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Affidavit, #2 Proposed Order) (Smoot, Rachel) |
Filing 17 MOTION for attorney Natasha L. White to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4493984) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Affidavit, #2 Proposed Order) (White, Natasha) |
Filing 16 MOTION for attorney Heinz J. Salmen to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4493969) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Affidavit, #2 Proposed Order) (Salmen, Heinz) |
Filing 15 MOTION for attorney Eric R. Hunt to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4493933) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Affidavit, #2 Proposed Order) (Hunt, Eric) |
Filing 14 MOTION for attorney Deanne M. Mazzochi to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4493926) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Affidavit, #2 Proposed Order) (Mazzochi, Deanne) |
Filing 13 MOTION for attorney William A. Rakoczy to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4493879) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Affidavit, #2 Proposed Order) (Rakoczy, William) |
Filing 12 WAIVER OF SERVICE Returned Executed by AMGEN INC, AMGEN MANUFACTURING LIMITED. MYLAN GMBH waiver sent on 9/27/2017, answer due 11/27/2017; MYLAN INC. waiver sent on 9/27/2017, answer due 11/27/2017; MYLAN N.V. waiver sent on 9/27/2017, answer due 11/27/2017; MYLAN PHARMACEUTICALS INC waiver sent on 9/27/2017, answer due 11/27/2017. (Baldauf, Kent) |
|
Filing 10 NOTICE that instant civil action has been designated for placement into the United States District Court's Alternative Dispute Resolution program. Parties are directed to fully complete the required 26(f) report, which includes the stipulation of selecting an ADR process. Counsel for plaintiff (or in the case of a removal action, counsel for removing defendant) shall make service of the notice on all parties. (jad) |
Filing 9 NOTICE of Appearance by John A. Schwab on behalf of MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Schwab, John) |
Filing 8 NOTICE of Appearance by William Pietragallo, II on behalf of MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Pietragallo, William) |
Filing 7 NOTICE of Appearance by Eric G. Soller on behalf of MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric) |
|
Judge David S. Cercone no longer assigned to case. (gmp) |
Judge Mark R. Hornak added. (gmp) |
Filing 5 NOTICE of Appearance by Cecilia R. Dickson on behalf of AMGEN INC, AMGEN MANUFACTURING LIMITED. (Dickson, Cecilia) |
Filing 4 NOTICE of Appearance by Thomas C. Wolski on behalf of AMGEN INC, AMGEN MANUFACTURING LIMITED. (Wolski, Thomas) |
Filing 3 PATENT/TRADEMARK DOCUMENTS ISSUED. (Attachments: #1 Complaint, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5) (plh) |
Filing 2 Disclosure Statement identifying None as corporate parent or other affiliate, by AMGEN INC. Amgen Manufacturing Limited subsidiary of Amgen Inc. (plh) |
Filing 1 COMPLAINT against MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC (Filing fee, including Administrative fee, $400, receipt number 4472128), filed by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Civil Cover Sheet, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5) (plh) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Pennsylvania Western District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.